Abstract
Hypertensive disorders in pregnancy remain a leading cause of maternal and perinatal mortality and morbidity. We aim to study urotensin II (UII) and its association with the markers of endoplasmic reticulum stress (ERS) in placentas of patients with severe preeclampsia (SPE). Thirty-three patients with hypertensive disorders in pregnancy and twenty-two healthy pregnant women designated as healthy controls were recruited. Expression levels of UII, UII receptor (GPR14) and the markers of ERS in placenta specimens of patients were performed. Plasma and urinary UII levels were measured by radioimmunoassay method. Our study showed that the plasma levels of UII in patients with hypertensive disorders during pregnancy were significantly higher than that of the healthy control group. However, the urinary levels of UII had no difference in two groups. The expression level of mRNA and protein of UII, CCAAT/enhancer-binding protein homologous protein (CHOP) and glucose regulation protein 78 in placentas of SPE was significantly increased. Immunohistochemical analyses show that the expression levels of UII and ERS markers were mainly located in the cytoplasm of placental trophoblastic cells. Moreover, expression level of UII mRNA and protein was positively correlated with that of the markers of ERS. The positive correlation between UII and ERS markers expression level also corresponded with the level of patient’s systolic blood pressure and proteinuria. In conclusion, we first verify that expression of UII is associated with ERS in patients with SPE. Our results indicate that UII may trigger ERS in placental trophoblastic cells in patients with preeclampsia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gould PS, Gu M, Liao JQ, Ahmad S, Cudmore MJ, Ahmed A et al. Up regulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia. Hypertension 2010; 56: 172–178.
Liane LA, Loset LM, Mundal SB, Fenstad MH, Johnson MP, Eide IP . Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia. Placenta 2011; 32: 823–829.
Eric AP, Dadelszen PV, Duvekot JJ, Pijnenborg R . Pre-eclampsia. Lancet 2010; 376: 631–644.
Veerbeek JH, Tissot Van Patot MC, Burton GJ, Yung HW . Endoplasmic reticulum stress is induced in the human placenta during labour. Placenta 2015; 36: 88–92.
Ames RS, Sarau HM, Chambers JK . Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999; 40: 282–286.
Balat O, Aksoy F, Kutlar I, Ugur MG, Iyikosker H, Balat A et al. Increased plasma levels of Urotensin-II in preeclampsia–eclampsia: a new mediator in pathogenesis? Eur J Obstet Gynecol Reprod Biol 2005; 120: 33–38.
Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N et al. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 2001; 19: 2185–2190.
Cowley E, Thompson JP, Sharpe P, Waugh J, Ali N, Lambert DG . Effects of pre-eclampsia on maternal plasma, cerebrospinal fluid, and umbilical cord urotensin II concentrations: a pilot study. Br J Anaesth 2005; 95: 495–499.
Jarry M, Diallo M, Lecointre C . The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte cell activity through common and distinct mechanisms: involvement in cell proliferation. Biochem J 2010; 428: 113–124.
Mekahli D, Bultynck G, Parys JB, Smedt HD, Missiaen L . Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb Perspect Biol 2011; 3: 1–30.
Bai Q, Zhang J, Zhang AH, Cheng LT, He L, Fan MH et al. Roles of human urotensin II in volume resistance hypertension in peritoneal dialysis patients. Ren Fail 2012; 340: 713–717.
Totsune K, Takahashi K, Arihara Z, Sone M, Ito S, Murakami O . Increased plasma urotensin II level s in patients with diabetes mellitus. Clin Sci 2003; 104 (1): 1–5.
Jain A, Olovsson M, Burton GJ, Yung HW . Endothelin-1 induces endoplasmic reticulum stress by activating the PLC-IP (3) pathway: implications for placental pathophysiology in preeclampsia. Am J Pathol 2012; 180: 2309–2320.
Acknowledgements
This study was supported by the National Natural Science Foundation (Grant No. 81170706 and Grant No 81341022) to A-H Zhang.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
He, WY., Chen, GJ., Lai, X. et al. Expression levels of urotensin II are associated with endoplasmic reticulum stress in patients with severe preeclampsia. J Hum Hypertens 30, 129–135 (2016). https://doi.org/10.1038/jhh.2015.28
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2015.28
This article is cited by
-
Expression of urotensin II is associated with placental autophagy in patients with severe preeclampsia
Journal of Human Hypertension (2018)